Task: Answer the multiple-choice question.
Question: Which drug exhibits a 42.647% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a CCn1c(CNc2ccc(OC)cc2)nnc1SCC(=O)Nc1ccc(F)cc1
b COc1ccc(CN2CCn3ncc(C(=O)Nc4ccc(Cl)cc4Cl)c3C2=O)cc1
c C/C(=N\NC(=O)C1COc2ccccc2O1)c1ccc(C)o1
d Cc1nc2ccc(NC(=O)COc3cccc(F)c3)cc2s1
Answer: d. Cc1nc2ccc(NC(=O)COc3cccc(F)c3)cc2s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nc2ccc(NC(=O)COc3cccc(F)c3)cc2s1
Cc1nc2ccc(NC(=O)COc3cccc(F)c3)cc2s1
2-(3-fluorophenoxy)-N-(2-methyl-1,3-benzothiazol-6-yl)acetamide